Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema (HAE)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00262080
What this trial is testing

Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 91
Testing effectiveness (Phase 2)Study completedNCT04208412
What this trial is testing

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05691361
What this trial is testing

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema
ADARx Pharmaceuticals, Inc. 53
Large-scale testing (Phase 3)Study completedNCT04654351
What this trial is testing

Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 2
Not applicableUnknownNCT03828279
What this trial is testing

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II

Who this might be right for
Hereditary Angioedema Type I and II
HAE Global Registry Foundation 220
Large-scale testing (Phase 3)Study completedNCT02316353
What this trial is testing

Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 126
Large-scale testing (Phase 3)Active Not RecruitingNCT06669754
What this trial is testing

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 81
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Post-approval studies (Phase 4)Study completedNCT00914966
What this trial is testing

Evaluate the Safety and Effect of Escalating Doses of CINRYZE

Who this might be right for
Hereditary Angioedema
Shire 20
Large-scale testing (Phase 3)Looking for participantsNCT07428499
What this trial is testing

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)Hereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc. 90
Post-approval studies (Phase 4)Looking for participantsNCT07654829
What this trial is testing

Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 100
Not applicableStudy completedNCT05147181
What this trial is testing

A Study With Lanadelumab in Persons With Hereditary Angioedema (HAE) in Poland

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 48
Not applicableStudy completedNCT01541423
What this trial is testing

A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 83
Large-scale testing (Phase 3)Active Not RecruitingNCT05392114
What this trial is testing

Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 154
Large-scale testing (Phase 3)Study completedNCT03888755
What this trial is testing

Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Who this might be right for
Hereditary Angioedema (HAE)
Shire 8
Not applicableStudy completedNCT04057131
What this trial is testing

FIRAZYR General Drug Use-Results Survey (Japan)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 179
Early research (Phase 1)Study completedNCT05118958
What this trial is testing

Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 37
Not applicableNot Yet RecruitingNCT07445087
What this trial is testing

Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 35
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Large-scale testing (Phase 3)Study completedNCT01005888
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 26
Next Page